Skip to main content
CYTK logo

CYTK

Cytokinetics, Incorporated

$76.22

6.79%

Trade Ideas Performance

Latest Closed Trade Idea

$76.22

6.79%
Loading...
We are loading your data. Please wait a moment.

Sentiment

News

57

Social

33

About

Events of Cytokinetics, Incorporated (CYTK)

Over the past six months, Cytokinetics' stock has experienced significant events. The stock price has shown a substantial increase over the past year, with a 52-week range between $29.31 and $80.20. The FDA approved MYQORZO in December 2025, followed by its U.S. commercial launch in January 2026, and the European Commission (EC) also approved MYQORZO. In May 2026, positive topline results from the ACACIA-HCM trial of aficamten in patients with non-obstructive hypertrophic cardiomyopathy (nHCM) were announced, contributing to a stock surge. Cytokinetics raised $760 million in a stock offering in May 2026. In April and May 2026, some senior executives sold shares, though they still retain sizable stakes. The company reported its first-quarter 2026 financial results in May 2026, highlighting strong demand for MYQORZO in its initial U.S. launch.

FAQ

Related Assets

Price action provided by Massive. Fundamentals, news and corporate events provided by FactSet. NLP support provided by Perplexity & Gemini. All data is provided for informational purposes only.

What Is Online Stock Trading and How Does the Market Work?

Online stock trading allows you to buy and sell shares of companies using digital platforms — all from your computer or phone. When you purchase a stock, you’re buying a small piece of that company. If the company performs well, its stock price usually goes up, and your investment gains value. If it struggles, the stock price may fall. All of this happens on stock exchanges, like the New York Stock Exchange or Nasdaq. These are marketplaces where investors and traders come together electronically. Prices change constantly based on supply and demand — the more people want a stock, the higher the price. If more people are selling, the price usually drops. Today, tools like Edge Hound, a generative AI trading assistant, make it easier for beginners to understand market trends and stay informed. What once required hours of manual research can now be streamlined using AI-powered insights.

Make every trade make sense.

Sign up free. No card required. Three trade ideas a day, the AI analyst, the community - on us.

Get started for FREE (opens in new tab)
Edge Hound mobile app preview on iPhone

Join us and trade with people
who think like you.

The Edge Hound Discord is where serious self-directed investors talk strategy, share setups, and learn from each other. Free to join with any plan - including Free.

Free to join with any plan - including Free.

Join our Discord community (opens in new tab)
Cytokinetics, Inc. (CYTK) Live Stock Price, Chart & Financial News | Edge Hound